Publications
Bioengineered Skeletal Muscle With Functional Stem Cell Pool and Capacity for Vascular Integration and Maturation In Vivo." In Molecular Therapy, S53-S54. Vol. 22. 2014.
"Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo." Proc Natl Acad Sci U S A 111, no. 15 (2014): 5508-5513.
" Cardiac fibroblasts in pressure overload hypertrophy: the enemy within?" The Journal of Clinical Investigation 124, no. 7 (2014): 2850-2853.
"Controlling the structural and functional anisotropy of engineered cardiac tissues." Biofabrication 6, no. 2 (2014): 24109.
"Gene Therapy for Heart Disease Using Electrically Active Fibroblasts." In Molecular Therapy, S144-S145. Vol. 22. 2014.
"Human Pluripotent Stem Cell-Derived Cardiac Tissue Patch for Use in Cell-Based Cardiac Therapy." In Molecular Therapy, S206. Vol. 22. 2014.
"Introduction to the special issue on tissue engineering and regenerative medicine." Annals of Biomedical Engineering 42, no. 7 (2014): 1355-1356.
"Maturation of functional cardiac tissue patches." (2014): 248-282.
"Physiology and metabolism of tissue-engineered skeletal muscle." Experimental Biology and Medicine 239, no. 9 (2014): 1203-1214.
"Quantifying electrical interactions between cardiomyocytes and other cells in micropatterned cell pairs." Methods in Molecular Biology (Clifton, N.J.) 1181 (2014): 249-262.
"Robust T-tubulation and maturation of cardiomyocytes using tissue-engineered epicardial mimetics." Biomaterials 35, no. 12 (2014): 3819-3828.
"Roles of adherent myogenic cells and dynamic culture in engineered muscle function and maintenance of satellite cells." Biomaterials 35, no. 35 (2014): 9438-9446.
" Tissue Engineered Human Skeletal Muscle as a Pre-Clinical Model for AAV Treatment of Pompe Disease." In Molecular Therapy, S157. Vol. 22. 2014.
"Use of flow, electrical, and mechanical stimulation to promote engineering of striated muscles." Annals of Biomedical Engineering 42, no. 7 (2014): 1391-1405.
"Design considerations for an integrated microphysiological muscle tissue for drug and tissue toxicity testing." Stem Cell Research & Therapy 4 Suppl 1 (2013).
"Engineering skeletal muscle repair." Current Opinion in Biotechnology 24, no. 5 (2013): 880-886.
"Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues." Plos One 8, no. 6 (2013): e65963.
"Spatial profiles of electrical mismatch determine vulnerability to conduction failure across a host-donor cell interface." Circulation. Arrhythmia and Electrophysiology 6, no. 6 (2013): 1200-1207.
"Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes." Biomaterials 34, no. 23 (2013): 5813-5820.
"Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming." Plos One 8, no. 5 (2013): e63577.
"WNT3 is a biomarker capable of predicting the definitive endoderm differentiation potential of hESCs." Stem Cell Reports 1, no. 1 (2013): 46-52.
"Calcium dependent CAMTA1 in adult stem cell commitment to a myocardial lineage." Plos One 7, no. 6 (2012): e38454.
"Colonizing the heart from the epicardial side." Stem Cell Research & Therapy 3, no. 2 (2012): 15.
"